Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population displaying experimental autoimmune encephalomyelitis at a point in time
go back to main search page
Accession:CMO:0001048 term browser browse the term
Definition:The number of individuals in a study population which display experimental autoimmune encephalomyelitis (EAE) at a certain point in time compared to the total number of individuals in the study population, expressed as a percentage. EAE is an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells.
Synonyms:exact_synonym: percentage of study population displaying experimental allergic encephalomyelitis at a point in time
 related_synonym: EAE prevalence;   experimental allergic encephalomyelitis prevalence;   experimental autoimmune encephalomyelitis prevalence



show annotations for term's descendants           Sort by:

Term paths to the root